ERA-Net NEURON Company Profile

12:40 EDT 19th June 2018 | BioPortfolio

EuroNanoMed aims at leveraging European Nanomedicine through the support of transnational collaborative and multidisciplinary research and technology development projects with participants from academia, clinical/public health communities, and industry. The ERA-Net EuroNanoMed was created to bridge the gap between academic research and industrial and clinical applications, encouraging the participation of small and medium enterprises. The ERA-Net EuroNanoMed initiative comprises 24 partners from 18 European Member- and associated states/regions. Additional information is available at

News Articles [92 Associated News Articles listed on BioPortfolio]

One experiment: A beautiful brain, neuron by neuron

What you see here is not a pointillist masterpiece. It is a rendering of the mouse brain, from above, formed by millions of colored dots. Like the famous canvases painted by post-Impressionist Georges...

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice

Accumulating evidence indicates that Tau pathology can spread from neuron to neuron by intake and coaggregation of the hyperphosphorylated Tau (p-Tau) seeds with the host neuron protein. Thus, clearan...

Studying Changing Neuron Size May Lead to New Therapies for Motor Neuron Disease

Scientists say they have improved our understanding of how motor neurons respond to motor neuron disease, which could help researchers identify new treatment options. The Wright State Univer...

Scientific 'dream team' shed light on motor neuron death

(The Francis Crick Institute) A group of clinical neurologists, molecular biologists and computer scientists have worked together to solve the mystery of why motor neurons die in patients with motor n...

Changing size of neurons could shed light on new treatments for motor neuron disease

New research improves our understanding of how motor nerve cells (neurons) respond to motor neuron disease, which could help us identify new treatment options.

Construction starts on Queen Mary University's 'Neuron Pod'

Construction has begun on ‘Neuron Pod’ – a 23-metre long free-standing structure which will be used as an informal science learning centre at the Queen Mary University of London.

Why motor neurons die in patients with motor neuron disease

A group of clinical neurologists, molecular biologists and computer scientists have worked together to solve the mystery of why motor neurons die in patients with motor neuron disease.

Calcium-based MRI sensor enables more sensitive brain imaging

(Massachusetts Institute of Technology) MIT neuroscientists have developed an MRI sensor that lets them monitor neuron activity deep within the brain by tracking calcium ions. This type of sensing cou...

PubMed Articles [319 Associated PubMed Articles listed on BioPortfolio]

The Drosophila Carbon Dioxide Receptor as Key Regulator of Odor Valence.

In this issue of Neuron, MacWilliam et al. (2018) show that the insect carbon dioxide receptor can also detect odorants from different chemical classes, the valence of which is determined by whether ...

The Map and the Territory: Mapping the Territory Regulated by Serotonergic Signaling at Striatal Projection Neurons.

In this issue of Neuron, Cavaccini et al. (2018) identify and thoroughly describe a previously unknown role for hyper-localized serotonergic signaling in the modulation of striatal projection neuron ...

Correction: Sensory Neuron-Derived Eph Regulates Glomerular Arbors and Modulatory Function of a Central Serotonergic Neuron.

[This corrects the article DOI: 10.1371/journal.pgen.1003452.].

Neuroscience: Past and Future.

Reflecting on when Neuron was launched and what the next 30 years may bring, neuroscientists share their excitement and visions for the future of the field.

Incorporating upper motor neuron health in ALS drug discovery.

Amyotrophic lateral sclerosis (ALS) is a complex disease, affecting the motor neuron circuitry. After consecutive failures in clinical trials for the past 20 years, edaravone was recently approved as ...

Clinical Trials [81 Associated Clinical Trials listed on BioPortfolio]

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

Levetiracetam (Keppra) is used to treat partial onset seizures. Its biological effects suggest it might also be useful in treating 3 aspects of human motor neuron diseases (MNDs) for whic...

Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases

The goal of this study is to establish a genetic registry of patients with early-onset motor neuron and neuromuscular diseases. The investigators will collect samples from patients with a ...

A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

The COMMEND Study will assess the safety and effectiveness of FLX-787 in men and women with Motor Neuron Disease [including Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis (...

Collection of Blood Samples for DNA in Motor Neuron Disease

This study will collect blood samples from patients with primary lateral sclerosis (PLS) and amyotrophic lateral sclerosis (ALS) to be used for research on genetic causes of motor neuron d...

Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease

Herein, we study the safety and efficacy of transplanting purified autologous bone marrow-derived stem cells transplanted via the intrathecal route by interventional radiology and the intr...

Companies [8 Associated Companies listed on BioPortfolio]

Neuron Therapeutics

Neuron Therapeutics, Inc. ("NTI") is a clinical-stage company developing unique therapies for the treatment of central nervous system (CNS) disorders through the application of proprietary pharmaceuti...

Biokeystone Company

In 1994 a company, Biokey American Instruments, was created in Portland, Oregon near the campus of Oregon Health & Science University. Late in 2006 after relocation to California, a company name...

Nova Molecular Incorporated

Nova Molecular Inc. (NMI) is a Montreal based CNS drug discovery company focused on understanding neuronal degeneration, disease progression, repair mechanisms, therapeutic response and development ba...

AveXis, Inc.

AveXis is a clinical-stage gene therapy company establishing unique industry alliances to create innovative treatments in areas of unmet medical needs. The company’s most adv...

Elsevier and Cell Press

Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the ...

More Information about "ERA-Net NEURON" on BioPortfolio

We have published hundreds of ERA-Net NEURON news stories on BioPortfolio along with dozens of ERA-Net NEURON Clinical Trials and PubMed Articles about ERA-Net NEURON for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ERA-Net NEURON Companies in our database. You can also find out about relevant ERA-Net NEURON Drugs and Medications on this site too.

Quick Search


Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Corporate Database Quicklinks

Searches Linking to this Company Record